A Message from the Director
Three Years of Progress
Here at the Taubman Institute, we are building on the momentum of three productive and exciting years.
We currently are funding four Senior Taubman Scholars and eight Taubman Scholars, who with our and your support are doing groundbreaking research that will have profound effects on the understanding and treatment of a range of diseases.
We also are working to create the collaborative environment that is one of the cornerstones of the Institute, where the exchange of ideas and creative interaction across disciplines are vigorously promoted.
This fall, for example, we kicked off our Visiting Professor lecture series with a presentation by Dr. Gary Landreth, a noted Alzheimer’s disease researcher from Case Western Reserve University. The lectures are open to the campus and about 60 students, scientists and physicians gathered to hear Dr. Landreth – who, by the way, earned one of the first three doctorates granted by U-M’s Neuroscience program.
We also hold brown-bag lunches -- where members of all the Taubman labs get together to discuss their research – and the scholars regularly gather for “chalk talks” to share, discuss and debate their findings.
And we are poised to host our fourth annual Taubman Institute Symposium on October 14 in Ann Arbor, with presentations by new Taubman scholars and a keynote address by Michigan Gov. Rick Snyder.
Throughout the coming months, I invite your continued interest in the work of the Taubman Institute. To keep up with our research and news from the laboratories, please bookmark our website at www.taubmaninsitute.org.
This is a very exciting era in the search for treatments of some of the most devastating illnesses that strike individuals and families. With the commitment of our scientists and the sustained support of people like Alfred Taubman, we are moving forward in our quest to challenge head-on some of today’s most deadly diseases.
Sincerely,
Eva Feldman, M.D., Ph.D., FAAN
Director, Taubman Medical Research Institute
Professor of Neurology, University of Michigan Medical School
Help Us Make A Difference. Make A Donation That Could Save Lives.
Taubman Science
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
Click here to read the interview
Clinical Trials
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Taubman Science
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
The Latest
Taubman Science
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
Accomplishments
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.
Donors pitch in to keep brilliant science minds at U-M Video
